Clinical Trials Directory

Trials / Terminated

TerminatedNCT01092975

Safety of Phenylephrine for Oral Mucositis Prevention

A Phase I Safety Study of Phenylephrine Applied Topically to the Oral Mucosa in Cancer Patients Receiving Radiation to Sub-mandibular Lymph Nodes

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
1 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if applying the drug phenylephrine to the inside of the mouth can be done safely and is tolerable to use in cancer patients receiving radiation to the Sub-mandibular lymph nodes.

Conditions

Interventions

TypeNameDescription
DRUGphenylephrine solutionSubjects will receive up to 40 dose of topical phenylephrine at the specified dose level.

Timeline

Start date
2010-03-01
Primary completion
2010-11-01
Completion
2011-04-01
First posted
2010-03-25
Last updated
2020-12-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01092975. Inclusion in this directory is not an endorsement.

Safety of Phenylephrine for Oral Mucositis Prevention (NCT01092975) · Clinical Trials Directory